Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
1
BFAM Quote, Financials, Valuation and Earnings
Last price:
$66.89
Seasonality move
:
2.16%
Day range:
$63.68 - $74.33
52-week range:
$63.68 - $132.99
Dividend yield:
0%
P/E ratio:
19.94x
P/S ratio:
1.31x
P/B ratio:
2.65x
Volume:
4.2M
Avg. volume:
831.1K
1-year change:
-43.78%
Market cap:
$3.8B
Revenue:
$2.9B
EPS (TTM):
$3.35
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2B | $2.4B | $2.7B | $2.9B | |
| Revenue Growth (YoY) | 15.86% | 15.11% | 19.69% | 11.07% | 9.22% | |
| Cost of Revenues | $1.4B | $1.6B | $1.9B | $2.1B | $2.2B | |
| Gross Profit | $345.5M | $374M | $484.8M | $632.2M | $691M | |
| Gross Profit Margin | 19.68% | 18.51% | 20.05% | 23.54% | 23.56% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $256.8M | $289.2M | $327.1M | $354.6M | -- | |
| Other Inc / (Exp) | -$2.6M | -$5.9M | -- | -- | -- | |
| Operating Expenses | $242.1M | $287.9M | $324.3M | $348.3M | $376.4M | |
| Operating Income | $103.4M | $86.2M | $160.5M | $283.9M | $314.7M | |
| Net Interest Expenses | $31.2M | $46.9M | $82M | $69.9M | $44.8M | |
| EBT. Incl. Unusual Items | $90.3M | $112.2M | $119.6M | $197.9M | $269.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.9M | $31.5M | $45.4M | $57.7M | $76.8M | |
| Net Income to Company | $70.5M | $80.6M | $74.2M | $140.2M | $193.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $70.2M | $80.3M | $74M | $140.2M | $193.1M | |
| Basic EPS (Cont. Ops) | $1.17 | $1.38 | $1.28 | $2.42 | $3.39 | |
| Diluted EPS (Cont. Ops) | $1.16 | $1.37 | $1.28 | $2.40 | $3.36 | |
| Weighted Average Basic Share | $60.3M | $58.3M | $57.7M | $57.9M | $56.9M | |
| Weighted Average Diluted Share | $60.9M | $58.5M | $57.9M | $58.5M | $57.4M | |
| EBITDA | $212.2M | $192.3M | $271.2M | $381.8M | $408.1M | |
| EBIT | $103.4M | $86.2M | $160.5M | $283.9M | $314.7M | |
| Revenue (Reported) | $1.8B | $2B | $2.4B | $2.7B | $2.9B | |
| Operating Income (Reported) | $103.4M | $86.2M | $160.5M | $283.9M | $314.7M | |
| Operating Income (Adjusted) | $103.4M | $86.2M | $160.5M | $283.9M | $314.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $462.7M | $529.5M | $615.6M | $674.1M | $733.7M | |
| Revenue Growth (YoY) | 22.7% | 14.45% | 16.27% | 9.5% | 8.83% | |
| Cost of Revenues | $370.3M | $445.2M | $509.4M | $535.8M | $593.2M | |
| Gross Profit | $92.3M | $84.3M | $106.3M | $138.3M | $140.5M | |
| Gross Profit Margin | 19.95% | 15.92% | 17.26% | 20.52% | 19.14% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $65.1M | $62.9M | $79.1M | $90.1M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $60.5M | $62.5M | $77.7M | $86.6M | $95M | |
| Operating Income | $31.8M | $21.7M | $28.6M | $51.8M | $45.5M | |
| Net Interest Expenses | $7.8M | $18.1M | $21.1M | $15.6M | $11.6M | |
| EBT. Incl. Unusual Items | $24.4M | $26.8M | $14M | $36.8M | $33.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7M | $8.7M | $8.5M | $7.7M | $12.1M | |
| Net Income to Company | $17.7M | $18M | $5.5M | $29.1M | $21.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $17.6M | $18M | $5.5M | $29.1M | $21.7M | |
| Basic EPS (Cont. Ops) | $0.30 | $0.31 | $0.10 | $0.50 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.29 | $0.31 | $0.09 | $0.50 | $0.38 | |
| Weighted Average Basic Share | $59.9M | $57.5M | $57.8M | $57.8M | $56.2M | |
| Weighted Average Diluted Share | $60.3M | $57.6M | $58.1M | $58.4M | $56.6M | |
| EBITDA | $57.8M | $49.9M | $56.5M | $74.1M | $70.2M | |
| EBIT | $31.8M | $21.7M | $28.6M | $51.8M | $45.5M | |
| Revenue (Reported) | $462.7M | $529.5M | $615.6M | $674.1M | $733.7M | |
| Operating Income (Reported) | $31.8M | $21.7M | $28.6M | $51.8M | $45.5M | |
| Operating Income (Adjusted) | $31.8M | $21.7M | $28.6M | $51.8M | $45.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2B | $2.4B | $2.7B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.7B | $2B | $2.1B | $2.2B | |
| Gross Profit | $345.5M | $359.9M | $448.9M | $601.3M | $691M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $256.8M | $289.2M | $327.1M | $354.6M | $281.4M | |
| Other Inc / (Exp) | -- | -$5.9M | -- | -- | -- | |
| Operating Expenses | $234.4M | $281.5M | $324.3M | $342.7M | $376.4M | |
| Operating Income | $111.1M | $78.4M | $124.6M | $258.6M | $314.7M | |
| Net Interest Expenses | $31.2M | $46.9M | $92M | $82.2M | $53.5M | |
| EBT. Incl. Unusual Items | $90.3M | $112.2M | $119.6M | $197.9M | $269.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.9M | $31.5M | $45.4M | $57.7M | $76.8M | |
| Net Income to Company | $70.5M | $80.6M | $74.2M | $140.2M | $193.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $70.2M | $80.3M | $74M | $140.2M | $193.1M | |
| Basic EPS (Cont. Ops) | $1.17 | $1.37 | $1.28 | $2.42 | $3.39 | |
| Diluted EPS (Cont. Ops) | $1.16 | $1.37 | $1.28 | $2.40 | $3.35 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $219.9M | $184.6M | $235.3M | $356.5M | $408.1M | |
| EBIT | $111.1M | $78.4M | $124.6M | $258.6M | $314.7M | |
| Revenue (Reported) | $1.8B | $2B | $2.4B | $2.7B | $2.9B | |
| Operating Income (Reported) | $111.1M | $78.4M | $124.6M | $258.6M | $314.7M | |
| Operating Income (Adjusted) | $111.1M | $78.4M | $124.6M | $258.6M | $314.7M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | $2.4B | $2.7B | $2.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $2B | $2.1B | $2.2B | -- | |
| Gross Profit | $359.9M | $448.9M | $601.3M | $691M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $289.2M | $327.1M | $354.6M | $281.4M | -- | |
| Other Inc / (Exp) | -$5.9M | -- | -- | -- | -- | |
| Operating Expenses | $281.5M | $324.3M | $342.7M | $376.4M | -- | |
| Operating Income | $78.4M | $124.6M | $258.6M | $314.7M | -- | |
| Net Interest Expenses | $46.9M | $92M | $82.2M | $53.5M | -- | |
| EBT. Incl. Unusual Items | $112.2M | $119.6M | $197.9M | $269.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.5M | $45.4M | $57.7M | $76.8M | -- | |
| Net Income to Company | $80.6M | $74.2M | $140.2M | $193.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $80.3M | $74M | $140.2M | $193.1M | -- | |
| Basic EPS (Cont. Ops) | $1.37 | $1.28 | $2.42 | $3.39 | -- | |
| Diluted EPS (Cont. Ops) | $1.37 | $1.28 | $2.40 | $3.35 | -- | |
| Weighted Average Basic Share | $233.4M | $230.9M | $231.7M | $227.8M | -- | |
| Weighted Average Diluted Share | $234M | $231.7M | $233.9M | $229.7M | -- | |
| EBITDA | $184.6M | $235.3M | $356.5M | $408.1M | -- | |
| EBIT | $78.4M | $124.6M | $258.6M | $314.7M | -- | |
| Revenue (Reported) | $2B | $2.4B | $2.7B | $2.9B | -- | |
| Operating Income (Reported) | $78.4M | $124.6M | $258.6M | $314.7M | -- | |
| Operating Income (Adjusted) | $78.4M | $124.6M | $258.6M | $314.7M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $288M | $57.4M | $109.3M | $133.3M | $140.1M | |
| Short Term Investments | $22.7M | $17.7M | $22M | $11.7M | -- | |
| Accounts Receivable, Net | $211M | $217.2M | $281.7M | $283.3M | $294M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $20.6M | $30.1M | $33.5M | $59.8M | -- | |
| Other Current Assets | $25M | $17.5M | $22.4M | $11.2M | -- | |
| Total Current Assets | $540.3M | $347.7M | $446.9M | $496M | $504M | |
| Property Plant And Equipment | $1.3B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Long-Term Investments | $22.1M | $59.7M | $47.8M | $42M | -- | |
| Goodwill | $1.5B | $1.7B | $1.8B | $1.8B | -- | |
| Other Intangibles | $251M | $245.6M | $216.6M | $197.6M | -- | |
| Other Long-Term Assets | $17.9M | $22.9M | $11.5M | $10.4M | -- | |
| Total Assets | $3.6B | $4.1B | $4.2B | $4.1B | $3.9B | |
| Accounts Payable | $8.5M | $24.6M | $24.8M | $32.8M | $292.8M | |
| Accrued Expenses | $188.9M | $206M | $234.3M | $271.7M | -- | |
| Current Portion Of Long-Term Debt | $16M | $16M | $18.5M | $28.5M | -- | |
| Current Portion Of Capital Lease Obligations | $87.3M | $94.1M | $100.4M | $102.1M | -- | |
| Other Current Liabilities | $20.7M | $15M | $12M | $12.3M | -- | |
| Total Current Liabilities | $622.2M | $786.3M | $799.4M | $779.4M | $966.2M | |
| Long-Term Debt | $1.7B | $1.8B | $1.7B | $1.7B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5B | $3B | $3B | $2.8B | $2.6B | |
| Common Stock | $59K | $58K | $58K | $57K | -- | |
| Other Common Equity Adj | -$37.4M | -$70.6M | -$59.1M | -$110.3M | -- | |
| Common Equity | $1.2B | $1.1B | $1.2B | $1.3B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $1.1B | $1.2B | $1.3B | $1.3B | |
| Total Liabilities and Equity | $3.6B | $4.1B | $4.2B | $4.1B | $3.9B | |
| Cash and Short Terms | $288M | $57.4M | $109.3M | $133.3M | $140.1M | |
| Total Debt | $1.7B | $1.8B | $1.8B | $1.7B | $1.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $288M | $57.4M | $109.3M | $133.3M | $140.1M | |
| Short Term Investments | $22.7M | $17.7M | $22M | $11.7M | -- | |
| Accounts Receivable, Net | $211M | $217.2M | $281.7M | $283.3M | $294M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $20.6M | $30.1M | $33.5M | $59.8M | -- | |
| Other Current Assets | $25M | $17.5M | $22.4M | $11.2M | -- | |
| Total Current Assets | $540.3M | $347.7M | $446.9M | $496M | $504M | |
| Property Plant And Equipment | $1.3B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Long-Term Investments | $22.1M | $59.7M | $47.8M | $42M | -- | |
| Goodwill | $1.5B | $1.7B | $1.8B | $1.8B | -- | |
| Other Intangibles | $251M | $245.6M | $216.6M | $197.6M | -- | |
| Other Long-Term Assets | $17.9M | $22.9M | $11.5M | $10.4M | -- | |
| Total Assets | $3.6B | $4.1B | $4.2B | $4.1B | $3.9B | |
| Accounts Payable | $197.4M | $230.6M | $259.1M | $304.5M | $292.8M | |
| Accrued Expenses | $188.9M | $206M | $234.3M | $271.7M | -- | |
| Current Portion Of Long-Term Debt | $16M | $16M | $18.5M | $28.5M | -- | |
| Current Portion Of Capital Lease Obligations | $87.3M | $94.1M | $100.4M | $102.1M | -- | |
| Other Current Liabilities | $20.7M | $15M | $12M | $12.3M | -- | |
| Total Current Liabilities | $622.2M | $786.3M | $799.4M | $779.4M | $966.2M | |
| Long-Term Debt | $1.7B | $1.8B | $1.7B | $1.7B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5B | $3B | $3B | $2.8B | $2.6B | |
| Common Stock | $59K | $58K | $58K | $57K | -- | |
| Other Common Equity Adj | -$37.4M | -$70.6M | -$59.1M | -$110.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $1.1B | $1.2B | $1.3B | $1.3B | |
| Total Liabilities and Equity | $3.6B | $4.1B | $4.2B | $4.1B | $3.9B | |
| Cash and Short Terms | $288M | $57.4M | $109.3M | $133.3M | $140.1M | |
| Total Debt | $1.7B | $1.8B | $1.8B | $1.7B | $1.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $70.5M | $80.6M | $74.2M | $140.2M | $193.1M | |
| Depreciation & Amoritzation | $108.8M | $106.1M | $110.7M | $97.9M | $93.4M | |
| Stock-Based Compensation | $23.1M | $28.1M | $28.8M | $33.6M | $30.6M | |
| Change in Accounts Receivable | -$34.6M | -$4.9M | -$64.5M | -$993K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $225.2M | $188.5M | $256.1M | $337.5M | $347.7M | |
| Capital Expenditures | $63.5M | $70.6M | $91M | $97.3M | $91.3M | |
| Cash Acquisitions | $53.9M | $210.4M | $39.6M | $8.3M | $6.8M | |
| Cash From Investing | -$117.4M | -$278M | -$126.9M | -$117.8M | -$103.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $992.3M | $295M | $402.5M | $156.5M | -- | |
| Long-Term Debt Repaid | -$1B | -$227M | -$502.5M | -$173.5M | -- | |
| Repurchase of Common Stock | $213.8M | $182.6M | -- | $84.6M | $225.4M | |
| Other Financing Activities | -$11.3M | -$20M | -$2.8M | -$109.2M | -- | |
| Cash From Financing | -$228M | -$121.3M | -$91.6M | -$183.8M | -$230.4M | |
| Beginning Cash (CF) | $265.3M | $39.7M | $87.3M | $121.6M | $140.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$123.2M | -$213.4M | $37.6M | $34.3M | $19.4M | |
| Ending Cash (CF) | $139.1M | -$176.1M | $124.9M | $154.2M | $165.5M | |
| Levered Free Cash Flow | $161.7M | $117.9M | $165.1M | $240.2M | $256.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $17.7M | $18M | $5.5M | $29.1M | $21.7M | |
| Depreciation & Amoritzation | $26M | $28.2M | $27.9M | $22.3M | $24.7M | |
| Stock-Based Compensation | $6.3M | $6.8M | $7.7M | $9M | $8.1M | |
| Change in Accounts Receivable | -$50.5M | -$21.3M | -$57.3M | -$53.4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $42M | $57.5M | $95.2M | $120.6M | $144.9M | |
| Capital Expenditures | $16.1M | $22.3M | $30.6M | $32.1M | $32.4M | |
| Cash Acquisitions | $35M | $988K | $1.9M | -- | $1.7M | |
| Cash From Investing | -$54.7M | -$27.1M | -$34.9M | -$25.1M | -$40.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $992.3M | $128M | $116.5M | -- | -- | |
| Long-Term Debt Repaid | -$1B | -$161M | -$149.9M | -$5M | -- | |
| Repurchase of Common Stock | $111.6M | -- | -- | $84.6M | $120.7M | |
| Other Financing Activities | -$1.6M | -$706K | -$196K | -$592K | -- | |
| Cash From Financing | -$141.9M | -$31.9M | -$31.2M | -$88M | -$87.5M | |
| Beginning Cash (CF) | $265.3M | $39.7M | $87.3M | $121.6M | $140.1M | |
| Foreign Exchange Rate Adjustment | -$898K | $1.5M | $1.3M | -$2.9M | $153K | |
| Additions / Reductions | -$155.5M | $47K | $30.3M | $4.6M | $17.2M | |
| Ending Cash (CF) | $108.9M | $41.3M | $118.9M | $123.3M | $157.4M | |
| Levered Free Cash Flow | $25.9M | $35.2M | $64.6M | $88.6M | $112.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $70.5M | $80.6M | $74.2M | $140.2M | $193.1M | |
| Depreciation & Amoritzation | $108.8M | $106.1M | $110.7M | $97.9M | $93.4M | |
| Stock-Based Compensation | $23.1M | $28.1M | $28.8M | $33.6M | $30.6M | |
| Change in Accounts Receivable | -$34.6M | -$4.9M | -$64.5M | -$993K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $225.2M | $188.5M | $256.1M | $337.5M | $347.7M | |
| Capital Expenditures | $63.5M | $70.6M | $91M | $97.3M | $91.3M | |
| Cash Acquisitions | $53.9M | $210.4M | $39.6M | $8.3M | $6.8M | |
| Cash From Investing | -$117.4M | -$278M | -$126.9M | -$117.8M | -$103.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $295M | $402.5M | $156.5M | -- | |
| Long-Term Debt Repaid | -$1B | -$227M | -$502.5M | -$173.5M | -- | |
| Repurchase of Common Stock | $213.8M | $182.6M | -- | $84.6M | $225.4M | |
| Other Financing Activities | -$11.3M | -$20M | -$2.8M | -$109.2M | -- | |
| Cash From Financing | -$228M | -$121.3M | -$91.6M | -$183.8M | -$230.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$123.2M | -$213.4M | $37.6M | $34.3M | $19.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $161.7M | $117.9M | $165.1M | $240.2M | $256.4M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $80.6M | $74.2M | $140.2M | $193.1M | -- | |
| Depreciation & Amoritzation | $106.1M | $110.7M | $97.9M | $93.4M | -- | |
| Stock-Based Compensation | $28.1M | $28.8M | $33.6M | $30.6M | -- | |
| Change in Accounts Receivable | -$4.9M | -$64.5M | -$993K | $38.5M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $188.5M | $256.1M | $337.5M | $347.7M | -- | |
| Capital Expenditures | $70.6M | $91M | $97.3M | $91.3M | -- | |
| Cash Acquisitions | $210.4M | $39.6M | $8.3M | $6.8M | -- | |
| Cash From Investing | -$278M | -$126.9M | -$117.8M | -$103.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $295M | $402.5M | $156.5M | $405M | -- | |
| Long-Term Debt Repaid | -$227M | -$502.5M | -$173.5M | -$454.5M | -- | |
| Repurchase of Common Stock | $182.6M | -- | $84.6M | $225.4M | -- | |
| Other Financing Activities | -$20M | -$2.8M | -$109.2M | -$16.5M | -- | |
| Cash From Financing | -$121.3M | -$91.6M | -$183.8M | -$230.4M | -- | |
| Beginning Cash (CF) | $618.7M | $276.1M | $447.1M | $579.8M | -- | |
| Foreign Exchange Rate Adjustment | -$2.5M | -$14K | -$1.6M | $5.9M | -- | |
| Additions / Reductions | -$213.4M | $37.6M | $34.3M | $19.4M | -- | |
| Ending Cash (CF) | $402.8M | $313.6M | $479.7M | $605.2M | -- | |
| Levered Free Cash Flow | $117.9M | $165.1M | $240.2M | $256.4M | -- | |
Get BFAM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BFAM
Sector
P/E ratio
19.94x
17.28x
PEG ratio
0.50x
0.11x
P/B ratio
2.65x
1.35x
Price / LTM sales
1.31x
0.59x
Growth Metrics
BFAM
Sector
Revenue growth
8.83%
2.98%
Earnings growth
-23.76%
-1.42%
Revenue (5-year growth)
14.13%
3.31%
Earnings forecast
$1.12
$0.29
Profitability
BFAM
Sector
Profitability FY 2025
$691M
$289.8M
Return on invested capital
6.2%
3.34%
Return on assets
4.92%
2.2%
Return on equity
14.27%
5.61%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
4
Estimated Next Earnings Date
May
14
Balance Sheet
BFAM
Sector
Total cash
$140.1M
$134.2M
Short term investments
$11.7M
$40.6M
Total assets
$3.9B
$1.1B
Long term debt
$1.7B
$31.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
